NADPH and Iron may have an important role in attenuated mucosal defense in Helicobacter pylori infection?

Mini-Reviews in Medicinal Chemistry

Volumn 10, Issue 14, 2010, Pages 1309-1315

  Dovhanj, J ^a   Kljaic, K ^b   Smolic, M ^c   Svagelj, D ^d  

^a JOSIP JURAJ STROSSMAYER UNIVERSITY OF OSIJEK   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c Department of Mineral Metabolism ^*  (Croatia)

^d School of Medicine Osijek   (Croatia)

Author keywords

Free radicals; Helicobacter pylori; Iron; NADPH

Indexed keywords

CHELATING AGENT; DEFEROXAMINE; FLAVOCYTOCHROME B558; GLUTATHIONE; IRON; NONHEME IRON PROTEIN; OXIDOREDUCTASE; OXYGEN; PENTOSE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; UNCLASSIFIED DRUG;

ARTICLE; DISEASE COURSE; ELECTRON TRANSPORT; ENZYME ACTIVATION; HELICOBACTER INFECTION; HUMAN; MUCOSAL IMMUNITY; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PENTOSE PHOSPHATE CYCLE; RESPIRATORY BURST;

ANIMALS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IRON; MUCOUS MEMBRANE; NADP; NADPH OXIDASE;

EID: 78649860750     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/138955710793564160     Document Type: Article

References (66)

1. Naito, Y.; Yoshikawa, T. Molecular and cellular mechanisms involved in Helicobacter pylori-induced inflammation and oxidative stress. Free Radic. Biol. Med., 2002, 33, 323-36.
2. Ohshima, H.; Bartsch, H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat. Res., 1994, 305, 253-264.
3. Akaike, T.; Ando, M.; Oda T.; Doi T.; Ijiri S.; Araki, S.; Maeda, H. Dependence on O2 generation by xanthine oxidase of pathogenesis of influenza virus infection in mice. J. Clin. Invest., 1990, 85, 739-745.
4. Valko, M.; Morris, H.; Cronin, M.T.D. Metals, toxicity and oxidative stress. Curr. Med. Chem., 2005, 12, 1161-1208.
5. Leonard, S. S., Harris, G. K.; Shi, X. Metal-induced oxidative stress and signal transduction. Free Radic. Biol. Med., 2004, 37, 1921-1942.
6. Pastor, N.; Weinstein, H.; Jamison, E.; Brenowitz, M. A detailed interpretation of OH radical footprints in a TBP DNAcomplex reveals the role of dynamics in the mechanism of sequence specific binding. J. Mol. Biol., 2000, 304, 55-68.
7. Kell, D.B. Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Med. Genet., 2009, 2, 1-79.
8. Lambeth, J.D. Regulation of the phagocyte respiratory burst oxidase by protein interactions. J. Biochem. Mol. Biol., 2000, 33,427-39.
9. Lieu, P.; Heiskala, M.; Peterson, P.; Yang, Y. The roles of iron in health and disease. Mol. Aspects. Med., 2001, 22,1-87.
10. Nauseef, W. Nox enzymes in immune cells. Semin. Immunopathol., 2008, 30, 195-208.
11. Benard, V.; Bokoch G.M.; Diebold, B.A. Potential drug targets: small GTPases that regulate leukocyte function. Trends Pharmacol. Sci., 1999, 20, 365-70.
12. Bokoch, G.; Knaus, U. NADPH oxidases: not just for leukocytes anymore. Trends Biochem. Sci., 2003, 28, 502-8.
13. Hashida, S.; Yuzawa, S.; Suzuki, N.; Fujioka, Y.; Takikawa, T.; Sumimoto, H.; Inagaki, F.; Fujii, H. Binding of FAD to cytochrome b558 is facilitated during activation of the phagocyte NADPH oxidase, leading to superoxide production. J. Biol. Chem., 2004, 279, 26378-86.
14. Isogai, Y.; Iizuka, T.; Shiro, Y. The mechanism of electron donation to molecular oxygen by phagocytic cytochrome b558. J. Biol. Chem., 1995, 270, 7853-7.
15. Allen, L.; McCaffrey, R. To activate or not to activate: distinct strategies used by Helicobacter pylori and Francisella tularensis to modulate the NADPH oxidase and survive in human neutrophils. Immunol. Rev,. 2007, 219,103-17.
16. Collins, H.; Kaufmann, S.; Schaible, U. Iron chelation via deferoxamine exacerbates experimental salmonellosis via inhibition of the nicotinamide adenine dinucleotide phosphate oxidase-dependent respiratory burst. J. Immunol., 2002, 168, 3458-63.
17. Wiedenheft, B.; Mosolf, J.; Willits, D.; Yeager, M.; Dryden, K. A.; Young, M.; Douglas, T. An archaeal antioxidant: characterization of a Dps like protein from Sulfolobus solfataricus. Proc. Natl. Acad. Sci. USA, 2005, 102, 10551-10556.
18. Zhao, G.; Ceci, P.; Ilari, A.; Giangiacomo, L.; Laue, T. M.; Chiancone, E.; Chasteen, N. D. Iron and hydrogen peroxide detoxification properties of DNA-binding protein from starved cells. A ferritin-like DNA-binding protein of Escherichia coli. J. Biol. Chem., 2002, 277, 27689-27696.
19. Dundon, W.G., Polenghi, A. Del Guidice, G.; Rappuoli, R.; Montecucco, C. Neutrophil-activating protein (HP-NAP) versus ferritin (Pfr): comparison of synthesis in Helicobacter pylori. FEMS Microbiol. Lett., 2001, 199, 143-149.
20. Nishioka, H.; Baesso, I.; Semenzato, G.; Trentin, L.; Rappuoli, R.; Del Giudice, G.; Montecucco, C. The neutrophil-activating protein of Helicobacter pylori (HP-NAP) activates the MAPK pathway in human neutrophils. Eur. J. Immunol., 2003, 33, 840-849.
21. Satin, B.; Del Giudice, G.; Della Bianca, V.; Dusi S.; Laudanna, C.; Tonello, F.; Kelleher, D.; Rappuoli, R.; Montecucco, C.; Rossi, F. The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor. J. Exp. Med., 2000, 191, 1467-1476.
22. Wang, G.; Hong, Y.; Olczak, A.; Maier, S.E.; Maier R.J. Dual roles of Helicobacter pylori NapA in inducing and combating oxidative stress. Infect. Immun., 2006, 74, 6839-6846.
23. Cappon, A.; Babolin, C.; Segat, D.; Cancian, L.; Amedei, A.; Calzetti, F.; Cassatella, M.A.; D'Elios, M.M.; Bernard, M. Helicobacter pylori-derived neutrophil-activating protein increases the lifespan of monocytes and neutrophils. Cell. Microbiol., 2010 (Articles online in advance of print)
24. Williams, J.; Arora, K.; Longenecker, J. The pentose pathway: a random harvest. Impediments which oppose acceptance of the classical (F-type) pentose cycle for liver, some neoplasms and photosynthetic tissue. The case for the L-type pentose pathway. Int. J. Biochem., 1987, 19, 749-817.
25. Porter, S.; Howarth, G.; Butler, R. Non-steroidal anti-inflammatory drugs and apoptosis in the gastrointestinal tract: potential role of the pentose phosphate pathways. Eur. J. Pharmacol., 2000, 397, 1-9.
26. Kletzien, R.; Harris, P.; Foellmi, L. Glucose-6-phosphate dehydrogenase: a "housekeeping" enzyme subject to tissue-specific regulation by hormones, nutrients, and oxidant stress. FASEB J., 1994, 8, 174-81.
27. Yajima, N.; Hiraishi, H.; Yamaguchi, N.; Ishida, M.; Shimada, T.; Terano, A. Monochloramine-induced cytolysis to cultured rat gastric mucosal cells: role of glutathione and iron in protection and injury. J. Lab. Clin. Med., 1999, 134, 372-7.
28. Tian, W.; Braunstein, L.; Pang, J.; Stuhlmeier, K., Xi, Q.; Tian, X., Stanton R. C. Importance of glucose-6-phosphate dehydrogenase activity for cell growth. J. Biol. Chem., 1998, 273, 10609-17.
29. Beil, W.; Obst, B.; Sewing, K.; Wagner, S. Helicobacter pylori reduces intracellular glutathione in gastric epithelial cells. Dig. Dis. Sci., 2000, 45, 1769-73.
30. Jung, H.; Lee, K.; Chu, S.; Yi, S. Reactive oxygen species activity, mucosal lipoperoxidation and glutathione in Helicobacter pyloriinfected gastric mucosa. J. Gastroenterol. Hepatol., 2001, 16, 1336-40.
31. Matthews, G.; Tivey, D.; Cummins, A.; Butler, R. Cellular mucosal defense is attenuated with chronicity of Helicobacter pylori infection. Dig. Dis. Sci., 2004, 49,1109-15.
32. Matthews, G.; Butler, R. Cellular mucosal defense during Helicobacter pylori infection: a review of the role of glutathione and the oxidative pentose pathway. Helicobacter, 2005, 10,298-306.
33. Liochev, S; Fridovich, I. The relative importance of HO* and ONOO- in mediating the toxicity of O*-. Free Radic Biol Med., 1999, 26, 777-8.
34. Valko, M.; Leibfritz, D.; Moncol, J.; Cronin, M.; Mazur, M.; Telser, J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell. Biol., 2007,39, 44-84.
35. Galaris, D.; Korantzopoulosm, P. On the molecular mechanism of metmyoglobin-catalyzed reduction of hydrogen peroxide by ascorbate. Free Radic. Biol. Med.,. 1997, 22, 657-67.
36. Galaris, D.; Cadenas, E.; Hochstein, P. Redox cycling of myoglobin and ascorbate: a potential protective mechanism against oxidative reperfusion injury in muscle. Arch. Biochem. Biophys., 1989, 273, 497-504.
37. Abraham, N.; Kappas, A. Heme oxygenase and the cardiovascularrenal system. Free Radic. Biol. Med., 2005,39,1-25.
38. Emerit, J.; Beaumont, C.; Trivin, F. Iron metabolism, free radicals, and oxidative injury. Biomed. Pharmacother., 2001, 55, 333-9.
39. Barbouti, A.; Amorgianiotis, C.; Kolettas, E.; Kanavaros, P.; Galaris, D. Hydrogen peroxide inhibits caspase-dependent apoptosis by inactivating procaspase-9 in an iron-dependent manner. Free. Radic. Biol. Med., 2007, 43, 1377-87.
40. Li, L.; Frei, B. Iron chelation inhibits NF-kappaB-mediated adhesion molecule expression by inhibiting p22 (phox) protein expression and NADPH oxidase activity. Arterioscler. Thromb. Vasc. Biol., 2006, 26, 2638-43.
41. Kartikasari, A.; Georgiou, N.; Visseren, F.; van Kats-Renaud, H.; van Asbeck, B.; Marx, J. Intracellular labile iron modulates adhesion of human monocytes to human endothelial cells. Arterioscler. Thromb. Vasc. Biol., 2004, 24, 2257-62.
42. Zhang, W.; Frei, B. Intracellular metal ion chelators inhibit TNFalpha-induced SP-1 activation and adhesion molecule expression in human aortic endothelial cells. Free. Radic. Biol. Med., 2003, 34, 674-82.
43. Patruta, S.I.; Horl, W.H. Iron and infection. Kidney Int., 1999, 55,125-30.
44. Jurado, R.L. Iron, infections, and anemia of inflammation. Clin. Infect. Dis., 1997, 25, 888-895.
45. Ganz, T. Molecular pathogenesis of anemia of chronic disease. Pediatr. Blood Cancer, 2005, 46, 554-7.
46. Ganz, T.; Nemeth, E. Regulation of iron acquisition and iron distribution in mammals. Biochim. Biophys. Acta, 2006, 1763,690-699.
47. Ganz, T.; Nemeth, E. Iron sequestration and anemia of inflammation. Semin. Hematol., 2009, 46, 387-393.
48. Keel, S.B.; Abkowitz, J.L. The Microcytic Red Cell and the Anemia of Inflammation. N. Engl. J. Med., 2009, 361, 1904-1906.
49. Nathan, C. Neutrophils and immunity: challenges and opportunities. Nat. Rev. Immunol., 2006, 6, 173-82.
50. Barabino, A. Helicobacter pylori-related iron deficiency anemia: a review. Helicobacter, 2002, 7, 71-5.
51. Kurtoglu, E.; Ugur, A.; Baltaci, A.; Mogolkoc, R.; Undar, L. Activity of neutrophil NADPH oxidase in iron-deficient anemia. Biol. Trace. Elem. Res., 2003, 96, 109-15.
52. Muhsen, K.; Cohen, D. Helicobacter pylori infection and iron stores: a systematic review and meta-analysis. Helicobacter, 2008, 13, 323-40.
53. Wang, G.; Conover, R.; Olczak, A.; Alamuri, P.; Johnson, M.; Maier, R. Oxidative stress defense mechanisms to counter ironpromoted DNA damage in Helicobacter pylori. Free. Radic. Res., 2005, 39,1183-91.
54. Bergman, M.; Salman, H.; Pinchasi, R.; Straussberg, R.; Djaldetti, M., Bessler, H. Phagocytic capacity and apoptosis of peripheral blood cells from patients with iron deficiency anemia. Biomed. Pharmacother., 2005, 59, 307-11.
55. Lee, J.; Choe, Y.; Choi, Y. The expression of iron-repressible outer membrane proteins in Helicobacter pylori and its association with iron deficiency anemia. Helicobacter, 2009, 14, 36-9.
56. Qu, X.-H.; Huang, X.-L.; Xiong, P.B.; Zhu, C.-Y.; Huang, Y.-L.; Lu, N.-G.; Sun, X.; Rong, L.; Zhong, L.; Sun, D.-Y.; Lin, H.; Cai, M.-C.; Chen, Z.-W.; Hu, B.; Wu, L.-M.; Jiang, Y.-B.; Yan, W.-L. Does Helicobacter pylori infection play a role in iron deficiency anemia? A meta-analysis. World J. Gastroenterol., 2010, 16, 886-896.
57. Duque, X., Moran, S.; Mera, R.; Medina, M.; Martinez, H.; Mendoza, M.E.; Torres, J.; Correa, P. Effect of eradication of Helicobacter pylori and iron supplementation on the iron status of children with iron deficiency. Archiv. Med. Res., 2010, 41, 38-45.
58. Yasui, K.; Baba, A. Therapeutic potential of superoxide dismutase (SOD) for resolution of inflammation. Inflamm. Res., 2006, 55, 359-363.
59. Miyoshi, N.; Takabayashi, S.; Osawa, T.; Nakamura, Y. Benzyl isothiocyanate inhibits excessive superoxide generation in inflammatory leukocytes: implication for prevention against inflammation-related carcinogenesis. Carcinogenesis, 2004, 25,567-75.
60. Blanchard, T.; Yu, F.; Hsieh, C.; Redline, R. Severe inflammation and reduced bacteria load in murine helicobacter infection caused by lack of phagocyte oxidase activity. J. Infect. Dis., 2003,187, 1609-15.
61. Matsuzaka, M.; Fukuda, S.; Yamai, K.; Tsuya, R.; Fukuoka, Y.; Takahashi, I.; Yaegaki, M.; Shimoyama, T.; Umeda, T.; Nakaji, S. Are individuals with lower neutrophil oxidative burst activity more prone to Helicobacter pylori infection? Luminescence, 2008, 23, 132-8.
62. Keenan J, Peterson Rn, Hampton M. NADPH oxidase involvement in the pathology of Helicobacter pylori infection. Free Radic. Biol. Med., 2005, 38, 1188-96.
63. Allen, L.; Beecher, B.; Lynch, J.; Rohner, O.; Wittine, L. Helicobacter pylori disrupts NADPH oxidase targeting in human neutrophils to induce extracellular superoxide release. J. Immunol., 2005, 174, 3658-67.
64. Chan, E.C.; Jiang, F.; Peshavariya, H.M.; Dusting, G.J. Regulation of cell proliferation by NADPH oxidase-mediated signaling: potential roles in tissue repair, regenerative medicine and tissue engineering. Pharmacol. Ther., 2009, 122, 97-108.
65. Dovhanj, J.; Kljaic, K.; Dodig-Curkovic, K.; Curkovic, M.; Volarevic, M.; Marjanovic, K. Helicobacter pylori, zinc and iron in oxidative stress-induced injury of gastric mucosa. Mini. Rev. Med. Chem., 2009, 9, 26-30.
66. Felley, C.; Pignatelli, B.; Van Melle, G.; Crabtree, J.; Stolte, M.; Diezi, J.Oxidative stress in gastric mucosa of asymptomatic humans infected with Helicobacter pylori: effect of bacterial eradication. Helicobacter, 2002, 7, 342-8.